Pancreatic cancer vaccine shows promise

mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer recurring in patients who initially respond.
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.
Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.
Vaccine shows promise for pancreatic cancer, study finds
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.
Groundbreaking study shows potential of new mRNA vaccine to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
Pancreatic cancer vaccine showing promise in early trial
Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.
Can You Personalize Your Pancreatic Cancer Vaccinations?
As per a new study, the potential of mRNA vaccines offers a personalized treatment for patients with pancreatic cancer.
Rolling Out6h
What to know about the latest vaccine updates
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
The Financial Express17h
New mRNA vaccine against tuberculosis effectively boosts immunity, study reveals
Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...
Hosted on MSN3d
Multiple states pushing to ban or restrict mRNA vaccines
The "Make America Healthy Again" commission is reviewing certain vaccines as some states push to restrict the use of COVID-19 ...
Bill to ban mRNA vaccines passes out of House committee
A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...
Franklin County wants health district to stop offering COVID vaccines
An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...
Hosted on MSN1d
Global influenza vaccine market to hit $14b by 2032
Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...
Combined organ-specific mRNA and lipid nanoparticle therapy could repair damaged lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
mRNA vaccine against tuberculosis shows efficacy in mice, results pave way for larger trials
Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity and offers better long-term protection compared to the ...